Deep Analysis Earnings Calendar About

Home
/CRDF Cardiff Oncology, Inc.
/Deep Analysis

Cardiff Oncology, Inc.CRDFEarnings & Financial Report

Nasdaq · Health Care · Biological Products, (No Diagnostic Substances)

Financial
Deep Analysis
Ownership
Annual Changes

VIR

Vir Biotechnology, Inc.

Revenue

$240.0K

Net Profit

$-163.1M

BKHA

Black Hawk Acquisition Corp

Revenue

$230.6K

Net Profit

$-3.8K

PROK

PROKIDNEY CORP.

Revenue

$225.0K

Net Profit

N/A

FFAI

FARADAY FUTURE INTELLIGENT ELECTRIC INC.

Revenue

$129.0K

Net Profit

$-33.6M

PTHS

Pelthos Therapeutics Inc.

Revenue

$294.0K

Net Profit

$-16.2M

ALGS

Aligos Therapeutics, Inc.

Revenue

$169.0K

Net Profit

N/A

ATHR

Aether Holdings, Inc.

Revenue

$338.8K

Net Profit

$-1.3M

INKT

MiNK Therapeutics, Inc.

Revenue

$111.2K

Net Profit

$-2.6M

VIR

Vir Biotechnology, Inc.

Revenue

$240.0K

Net Profit

$-163.1M

BKHA

Black Hawk Acquisition Corp

Revenue

$230.6K

Net Profit

$-3.8K

PROK

PROKIDNEY CORP.

Revenue

$225.0K

Net Profit

N/A

FFAI

FARADAY FUTURE INTELLIGENT ELECTRIC INC.

Revenue

$129.0K

Net Profit

$-33.6M

PTHS

Pelthos Therapeutics Inc.

Revenue

$294.0K

Net Profit

$-16.2M

ALGS

Aligos Therapeutics, Inc.

Revenue

$169.0K

Net Profit

N/A

ATHR

Aether Holdings, Inc.

Revenue

$338.8K

Net Profit

$-1.3M

INKT

MiNK Therapeutics, Inc.

Revenue

$111.2K

Net Profit

$-2.6M

The financial landscape of a US public company. Updated every quarter.

Explore

Home
Deep Analysis
Earnings Calendar

About

About
Terms
Contact Us

For informational purposes only. Not financial advice.

© 2026 10q10k.net · All rights reserved.